Fractyl Health, Inc. insiders have been one-way buyers this past year: five people put roughly $187,000 into the stock and nobody sold on the open market.
Biggest single buyer: BRADLEY WILLIAM, Director, with roughly $50,000. That includes C-suite money, which tends to get the most attention.
2 quarters in a row of net buying by insiders. Insiders bought in 4 of the last 7 full quarters. 75 investment managers listed GUTS in their latest 13F filings (Q2 2026); more funds sold than bought.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | BRADLEY WILLIAM | Director | Buy | 64,516 | $0.62 | $40K | SEC |
| Jun 15, 2026 | Royan Ajay | Director | Buy | 23,000 | $0.85 | $20K | SEC |
| Jun 11, 2026 | BRADLEY WILLIAM | Director | Buy | 68,493 | $0.73 | $50K | SEC |
| Jun 11, 2026 | Sheffield Ian | Director | Buy | 35,000 | $0.73 | $26K | SEC |
| Jun 11, 2026 | Rajagopalan Harith | CEO | Buy | 25,000 | $0.73 | $18K | SEC |
| Jun 9, 2026 | Smith Weber Lara | CFO | Buy | 20,000 | $0.69 | $14K | SEC |
| Dec 8, 2025 | Rajagopalan Harith | CEO | Buy | 10,416 | $1.92 | $20K | SEC |
| Mar 18, 2025 | Royan Ajay | Director | Buy | 17,901 | $1.28 | $23K | SEC |
| Mar 18, 2025 | Barnes Kelly Ann | Director | Buy | 31,000 | $1.30 | $40K | SEC |
| Mar 17, 2025 | SCHULMAN AMY W | Director | Buy | 8,550 | $1.17 | $10K | SEC |
| Mar 17, 2025 | BRADLEY WILLIAM | Director | Buy | 16,129 | $1.26 | $20K | SEC |
| Mar 17, 2025 | Conaway Samuel | Director | Buy | 8,550 | $1.17 | $10K | SEC |
| Feb 3, 2025 | Rajagopalan Harith | CEO | Sell | 90,972 | $1.82 | $166K | SEC |
| Feb 3, 2025 | Rajagopalan Harith | CEO | Sell | 20,948 | $1.95 | $41K | SEC |
| Feb 3, 2025 | Caplan Jay David | President | Sell | 22,346 | $1.81 | $40K | SEC |
In the last 12 months Fractyl Health, Inc. insiders made open-market purchases worth about $187,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in GUTS was filed on 2026-09-16.
75 investment managers reported holding GUTS in SEC Form 13F filings for Q2 2026.
No congressional trades in GUTS were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).